HealthFeb 25
Novo Nordisk Announces Price Cuts and Partnership Deal for Obesity Medications
Novo Nordisk will reduce U.S. prices for Ozempic and Wegovy by up to 50% while partnering with Vivtex in a potential $2.1 billion deal for oral obesity drugs.
0 sources

